医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Hytera Actively Participates in the Fight Against COVID-19, Helping to Prevent Cross-infections

2020年04月09日 PM09:35
このエントリーをはてなブックマークに追加


 

SHENZHEN, China

As of April 9, 2020, more than 1.5 million people have been diagnosed with COVID-19 worldwide, according to data from the World Health Organization (WHO). At this critical moment, Hytera, as a global leading provider of professional and private wireless communication networks, has taken immediate actions to provide diversified products in donations and service support to the countries and regions facing serious outbreaks of COVID-19. In addition, the company has also quickly tasked its smart production factory to switch over to mask production. A total of 1 million masks have already been donated by Hytera to Uzbekistan, the Philippines, Thailand, Myanmar, Russia, South Africa and other countries.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200409005427/en/

A total of 1 million masks have already been donated by Hytera to Uzbekistan, the Philippines, Thailand, Myanmar, Russia, South Africa and other countries. (Photo: Business Wire)

A total of 1 million masks have already been donated by Hytera to Uzbekistan, the Philippines, Thailand, Myanmar, Russia, South Africa and other countries. (Photo: Business Wire)

To support emergency response efforts against COVID-19, Hytera has donated DMR radios to Chevra Hatzalah to help protect their volunteers in New York City, the national epicenter of the COVID-19 pandemic. Chevra Hatzalah is the largest volunteer emergency medical service (EMS) organization in the world, with operations in 16 countries serving mostly Jewish communities.

One of the core values of professional and private wireless communications is to provide critical communications and command and dispatch support to governments and first response agencies to help ensure public safety during critical situations.

Globally, Hytera’s business solutions have been deployed throughout more than 120 countries and regions, and are used in private communications for public safety, transportation, emergency rescue and operator services to fight COVID-19. At present, many hospitals and police authorities in Spain, the United Kingdom, the Philippines, and Korea are fighting the outbreak with the support of Hytera’s communications solutions. In Abu Dhabi, a curfew was imposed as part of the prevention efforts during the epidemic. The police used Hytera’s multi-mode advanced radios to help control the movement of people in public areas.

Hytera is empowering people to manage and resolve the chaos created by the COVID-19 outbreak, and providing protection to prevent cross-infections among customs officers conducting border inspections, government officials discussing anti-epidemic programs and carrying out supervision, police monitoring checkpoints during the outbreak, rescue agencies deploying epidemic prevention materials and medical staff confronting the disease on the frontlines.

As a manufacturing company with world-class intelligent production capabilities, since February 10, Hytera has rapidly leveraged its advantages in intelligent production and supply chain integration to establish three production lines for mask production. Currently, Hytera has achieved a daily capacity of 200,000 masks.

Beyond the efforts highlighted above, Hytera has also been developing its Pandemic Prevention Solution which focuses on supporting customs border inspections, hospital management and enterprise inspections, which will go to the market around April 10.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200409005427/en/

CONTACT

Shaowa Cai

Shaowa.cai@hytera.com

 

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Arbitrator Rules in Favor of Daiichi Sankyo in Dispute with Seagen
  • InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China
  • Disclosure of data on Agaricus blazei mushroom, KA21′s immunity-enhancing mechanism, immunological enhancement effect confirmed by human clinical trials, and candida and other types of fungal infection, Toei Shinyaku
  • Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku
  • Survey of degree of satisfaction with Agaricus blazei mushroom KA21 for promoting the health of senior dogs and cats among veterinarians and pet owners, Toei Shinyaku